Table 3.
Concernsd | ||||||||
---|---|---|---|---|---|---|---|---|
Independent Variablese | a | b | c | d | e | f | g | h |
Side Effects | Hassle | Expense | Inability To Remember | Lack Of evidence | Not Wanting To Use Med | Normal Or Low Blood Pressure | No Concern | |
Sexf | – | – | – | – | – | – | – | – |
Male | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Female | 0.93 | 0.66 | 1.10 | 0.69 | 0.75a | 0.53a | 1.77b | 1.01 |
p-valueg | 0.68 | 0.06 | 0.51 | 0.24 | 0.05 | 0.02 | 0.001 | 0.97 |
Age (year)h | – | – | – | – | – | – | – | – |
≤50 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
51–60 | 0.75 | 0.59a | 0.65a | 0.38a | 0.94 | 0.77 | 1.19 | 1.24 |
61–70 | 0.58a | 0.41b | 0.38c | 0.45a | 0.93 | 0.80 | 1.15 | 2.04a |
71–80 | 0.51b | 0.32b | 0.16c | 0.54 | 1.02 | 0.82 | 1.53 | 1.85 |
≥81 | 0.29b | Omittedi | 0.13c | 0.50 | 0.94 | 0.58 | 0.67 | 3.55b |
p-valueg | 0.01 | <0.001 | <0.001 | 0.11 | 0.98 | 0.92 | 0.36 | 0.06 |
Race | – | – | – | – | – | – | – | – |
White | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Black | 0.62 | 0.76 | 1.55 | Omittedi | 1.54 | Omittedi | 0.87 | 1.39 |
Asian | 0.50 | 2.65a | 0.86 | 3.57a | 0.94 | 2.87a | 2.48 | 0.38 |
Other | 1.19 | 1.53 | 1.38 | 1.15 | 1.02 | 1.20 | 1.14 | 0.63 |
p-valueg | 0.34 | 0.11 | 0.62 | 0.06 | 0.93 | 0.11 | 0.41 | 0.64 |
Ethnicity | – | – | – | – | – | – | – | – |
Non-hispanic | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Hispanic | 1.39 | 0.94 | 1.16 | 0.42 | 1.18 | 2.14 | 0.46 | 1.27 |
p-valueg | 0.47 | 0.90 | 0.72 | 0.43 | 0.66 | 0.17 | 0.05 | 0.67 |
Education | – | – | – | – | – | – | – | – |
≤High school graduate | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Some college | 1.12 | 0.76 | 1.44 | 1.13 | 1.15 | 0.71 | 0.67 | 0.88 |
College graduate | 1.48 | 0.88 | 1.19 | 1.00 | 1.34 | 1.15 | 0.99 | 0.51 |
Some post-graduate | 1.69 | 1.27 | 1.57 | 1.03 | 1.25 | 2.04 | 0.99 | 0.79 |
Post graduate degree | 1.77 | 1.09 | 1.22 | 0.81 | 1.43 | 1.10 | 0.96 | 0.56 |
p-valueg | 0.09 | 0.55 | 0.46 | 0.90 | 0.57 | 0.11 | 0.26 | 0.13 |
Income ($) | – | – | – | – | – | – | – | – |
<35,000 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
35,000–49,999 | 0.78 | 0.57 | 0.98 | 0.54 | 1.07 | 0.63 | 1.80a | 1.31 |
50,000–74,999 | 0.75 | 0.67 | 0.67 | 0.60 | 0.86 | 0.52 | 1.14 | 1.40 |
75,000–99,999 | 0.89 | 0.80 | 0.47b | 0.37a | 1.09 | 0.57 | 1.37 | 1.10 |
≥100,000 | 0.50b | 0.62 | 0.34c | 0.28b | 0.81 | 0.38a | 1.54 | 2.04a |
p-valueg | 0.01 | 0.50 | <0.001 | 0.02 | 0.33 | 0.16 | 0.17 | 0.10 |
Notes: ap<0.05, bp<0.01, cp<0.001; d(a) Side effects from the medication, (b) Hassle to take medication every day, (c) Expense/cost of the medication, (d) Inability to remember to take medication when I should, (e) Lack of evidence showing that this will reduce my risk, (f) Do not want to use a medication, (g) My blood pressure is already normal or low, and (h) I have no concerns; eCurrent use of antihypertensives was included in each model as an independent variable; fThose who identified themselves as non-binary were omitted due to a very small sample size; gp-value from Wald test, adjusted for all other covariates; hAge categories below 40 and 41–50 were combined; iDummy variables were omitted due to a perfect correlation with the outcome variable.